Article Versions Notes

Guo J, Meng W, Li Q, Zheng Y, Yin H, Liu Y, Zhao S, Ma J. Pretreatment Sarcopenia and MRI-Based Radiomics to Predict the Response of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. Bioengineering. 2024; 11(7):663. https://doi.org/10.3390/bioengineering11070663

Guo, Jiamin, Wenjun Meng, Qian Li, Yichen Zheng, Hongkun Yin, Ying Liu, Shuang Zhao, and Ji Ma. 2024. "Pretreatment Sarcopenia and MRI-Based Radiomics to Predict the Response of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer" Bioengineering 11, no. 7: 663. https://doi.org/10.3390/bioengineering11070663

Guo, J., Meng, W., Li, Q., Zheng, Y., Yin, H., Liu, Y., Zhao, S., & Ma, J. (2024). Pretreatment Sarcopenia and MRI-Based Radiomics to Predict the Response of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. Bioengineering, 11(7), 663. https://doi.org/10.3390/bioengineering11070663